Peciu-Florianu, Iulia
Vannod-Michel, Quentin
Vauleon, Enora
Bonneterre, Marie-Edith
Reyns, Nicolas http://orcid.org/0000-0002-1206-9342
Article History
Received: 17 March 2024
Accepted: 22 April 2024
First Online: 16 May 2024
Declarations
:
: All procedures performed in studies were in accordance with the ethical standards of the National Research Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The French National Agency for Medicine and Health Product Safety (ANSM) as well as the French National Ethics Committee approved this study.
: Informed consent was obtained from all individual participants included in the study.
: All subject authorized the publication anonymously of their data.
: N. Reyns is one of the co-founders of Hemerion Therapeutics SAS, Lille, France. M.-E. Bonneterre is Chief Medical Officer of Hemerion Therapeutics SAS, Lille, France.